272 related articles for article (PubMed ID: 20041189)
21. Histopathology of lupus-like nephritis in Dnase1-deficient mice in comparison to NZB/W F1 mice.
Jacob M; Napirei M; Ricken A; Dixkens C; Mannherz HG
Lupus; 2002; 11(8):514-27. PubMed ID: 12220106
[TBL] [Abstract][Full Text] [Related]
22. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
[TBL] [Abstract][Full Text] [Related]
23. Increased glomerular matrix metalloproteinase activity in murine lupus nephritis.
Tveita AA; Rekvig OP; Zykova SN
Kidney Int; 2008 Nov; 74(9):1150-8. PubMed ID: 18596727
[TBL] [Abstract][Full Text] [Related]
24. Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease.
Zeisberg M; Khurana M; Rao VH; Cosgrove D; Rougier JP; Werner MC; Shield CF; Werb Z; Kalluri R
PLoS Med; 2006 Apr; 3(4):e100. PubMed ID: 16509766
[TBL] [Abstract][Full Text] [Related]
25. Glomerular matrix metalloproteinases and their regulators in the pathogenesis of lupus nephritis.
Tveita A; Rekvig OP; Zykova SN
Arthritis Res Ther; 2008; 10(6):229. PubMed ID: 19090960
[TBL] [Abstract][Full Text] [Related]
26. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
Sjöwall C; Olin AI; Skogh T; Wetterö J; Mörgelin M; Nived O; Sturfelt G; Bengtsson AA
Autoimmunity; 2013 May; 46(3):205-14. PubMed ID: 23331132
[TBL] [Abstract][Full Text] [Related]
27. Infusion of anti-DFS70 antibodies prolonged survival of lupus-prone mice.
Aljadeff G; Shemer A; Katz I; Andrade LEC; Gilburd B; Halpert G; Mahler M; Blank M; Amital H; Shoenfeld Y
Lupus; 2021 Feb; 30(2):320-324. PubMed ID: 33175665
[TBL] [Abstract][Full Text] [Related]
28. Murine and Human Lupus Nephritis: Pathogenic Mechanisms and Theoretical Strategies for Therapy.
Pedersen HL; Horvei KD; Thiyagarajan D; Seredkina N; Rekvig OP
Semin Nephrol; 2015 Sep; 35(5):427-38. PubMed ID: 26573545
[TBL] [Abstract][Full Text] [Related]
29. Anti-ribosomal-P antibodies accelerate lupus glomerulonephritis and induce lupus nephritis in naïve mice.
Ben-Ami Shor D; Blank M; Reuter S; Matthias T; Beiglass I; Volkov A; Barshack I; Shoenfeld Y
J Autoimmun; 2014 Nov; 54():118-26. PubMed ID: 24662148
[TBL] [Abstract][Full Text] [Related]
30. Nephritogenicity of anti-proteoglycan antibodies in experimental murine lupus nephritis.
Kashihara N; Makino H; Szekanecz Z; Waltenbaugh CR; Kanwar YS
Lab Invest; 1992 Dec; 67(6):752-60. PubMed ID: 1460866
[TBL] [Abstract][Full Text] [Related]
31. Nephritogenic antibodies bind in glomeruli through interaction with exposed chromatin fragments and not with renal cross-reactive antigens.
Mjelle JE; Rekvig OP; Van Der Vlag J; Fenton KA
Autoimmunity; 2011 Aug; 44(5):373-83. PubMed ID: 21244336
[TBL] [Abstract][Full Text] [Related]
32. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
Liao W; Zheng H; Wu S; Zhang Y; Wang W; Zhang Z; Zhou C; Wu H; Min J
Am J Nephrol; 2017; 46(5):371-379. PubMed ID: 29069649
[TBL] [Abstract][Full Text] [Related]
33. Circulating chromatin-anti-chromatin antibody complexes bind with high affinity to dermo-epidermal structures in murine and human lupus nephritis.
Fismen S; Hedberg A; Fenton KA; Jacobsen S; Krarup E; Kamper AL; Rekvig OP; Mortensen ES
Lupus; 2009 Jun; 18(7):597-607. PubMed ID: 19433459
[TBL] [Abstract][Full Text] [Related]
34. A case of lupus nephritis with diffuse podocytic infolding into the glomerular basement membrane.
Mii A; Shimizu A; Masuda Y; Ishizaki M; Sato S; Hara K; Kaneko T; Utsumi K; Iino Y; Katayama Y; Fukuda Y
Clin Exp Nephrol; 2008 Dec; 12(6):479-84. PubMed ID: 18958394
[TBL] [Abstract][Full Text] [Related]
35. Cross-reaction of anti-DNA autoantibodies with membrane proteins of human glomerular mesangial cells in sera from patients with lupus nephritis.
Du H; Chen M; Zhang Y; Zhao MH; Wang HY
Clin Exp Immunol; 2006 Jul; 145(1):21-7. PubMed ID: 16792669
[TBL] [Abstract][Full Text] [Related]
36. Autoimmunity against nucleosomes and lupus nephritis.
Van Bruggen MC; Kramers C; Berden JH
Ann Med Interne (Paris); 1996; 147(7):485-9. PubMed ID: 9092359
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of FoxO3a expression through PI3K/Akt pathway attenuates the progression of lupus nephritis in MRL/lpr mice.
Zhao C; Gu Y; Chen L; Su X
Int Immunopharmacol; 2020 Dec; 89(Pt A):107027. PubMed ID: 33039957
[TBL] [Abstract][Full Text] [Related]
38. Glomerular cell apoptosis in human lupus nephritis.
Makino H; Sugiyama H; Yamasaki Y; Maeshima Y; Wada J; Kashihara N
Virchows Arch; 2003 Jul; 443(1):67-77. PubMed ID: 12750884
[TBL] [Abstract][Full Text] [Related]
39. Silencing HE4 alleviates the renal fibrosis in lupus nephritis mice by regulating the C3/MMPs/prss axis.
Li Y; Zhong X; Yang F
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):4823-4831. PubMed ID: 38157023
[TBL] [Abstract][Full Text] [Related]
40. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
